BAX - Baxter International Inc.
NYSE
->
Healthcare
->
Medical Instruments & Supplies
Deerfield,
United States
Type: Equity
BAX price evolution
BAX
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2095 | $3026 | $3194 | |
| Short term investments | ||||
| Net receivables | $1783 | $2692 | $2521 | $2690 |
| Inventory | $2103 | $2985 | $2988 | $2824 |
| Total current assets | $8864 | $8593 | $9400 | $9600 |
| Long term investments | ||||
| Property, plant & equipment | $3160 | $4838 | $4901 | $4957 |
| Goodwill & intangible assets | $11742 | $12335 | $12593 | |
| Total noncurrent assets | $17719 | $18388 | $18676 | |
| Total investments | ||||
| Total assets | $26676 | $26312 | $27788 | $28276 |
| Current liabilities | ||||
| Accounts payable | $841 | $1251 | $1329 | $1241 |
| Deferred revenue | ||||
| Short long term debt | $2468 | $2634 | $2668 | |
| Total current liabilities | $6200 | $6131 | $6365 | $6503 |
| Long term debt | $10437 | $10436 | $11536 | $11568 |
| Total noncurrent liabilities | $12473 | $13188 | $13305 | |
| Total debt | $13343 | $14170 | $14236 | |
| Total liabilities | $18804 | $18669 | $19553 | $19808 |
| Shareholders' equity | ||||
| Retained earnings | $15529 | $15539 | $16003 | $16114 |
| Other shareholder equity | -$3647 | -$3828 | -$3722 | -$3554 |
| Total shareholder equity | $7643 | $8173 | $8402 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3194 | $1718 | $2951 | $3730 |
| Short term investments | ||||
| Net receivables | $2690 | $2752 | $2629 | $2077 |
| Inventory | $2824 | $2718 | $2453 | $1916 |
| Total current assets | $9600 | $8011 | $8872 | $8411 |
| Long term investments | $135 | |||
| Property, plant & equipment | $4957 | $5529 | $5808 | $5325 |
| Goodwill & intangible assets | $12593 | $13636 | $17628 | $4888 |
| Total noncurrent assets | $18676 | $20276 | $24649 | $11608 |
| Total investments | ||||
| Total assets | $28276 | $28287 | $33521 | $20019 |
| Current liabilities | ||||
| Accounts payable | $1241 | $1139 | $1246 | $2927 |
| Deferred revenue | ||||
| Short long term debt | $2668 | $1404 | $511 | $406 |
| Total current liabilities | $6503 | $4745 | $4236 | $3333 |
| Long term debt | $11568 | $15232 | $17671 | $6287 |
| Total noncurrent liabilities | $13305 | $17647 | $20164 | $7960 |
| Total debt | $14236 | $17092 | $18182 | $6693 |
| Total liabilities | $19808 | $22454 | $24400 | $11293 |
| Shareholders' equity | ||||
| Retained earnings | $16114 | $14050 | $17065 | $16328 |
| Other shareholder equity | -$3554 | -$3833 | -$3380 | -$3314 |
| Total shareholder equity | $8402 | $5833 | $9077 | $8689 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2699 | $3812 | $3592 | $3885 |
| Cost of revenue | $2381 | $2205 | $2413 | |
| Gross Profit | $1033 | $1431 | $1387 | $1472 |
| Operating activities | ||||
| Research & development | $173 | $176 | $172 | |
| Selling, general & administrative | $1021 | $1027 | $985 | |
| Total operating expenses | $878 | $1623 | $1200 | $1143 |
| Operating income | -$192 | $187 | $329 | |
| Income from continuing operations | ||||
| EBIT | -$175 | $192 | $483 | |
| Income tax expense | $8 | $54 | $77 | $165 |
| Interest expense | -$87 | $85 | $78 | $73 |
| Net income | ||||
| Net income | $140 | -$314 | $37 | $245 |
| Income (for common shares) | -$314 | $37 | $245 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14813 | $15113 | $12784 | $11673 |
| Cost of revenue | $9838 | $9716 | $7679 | $7086 |
| Gross Profit | $4975 | $5397 | $5105 | $4587 |
| Operating activities | ||||
| Research & development | $667 | $605 | $534 | $521 |
| Selling, general & administrative | $3946 | $3887 | $2867 | $2469 |
| Total operating expenses | $4585 | $7340 | $3395 | $2971 |
| Operating income | $390 | -$1943 | $1710 | $1616 |
| Income from continuing operations | ||||
| EBIT | $3064 | -$1970 | $1658 | $1418 |
| Income tax expense | -$34 | $68 | $182 | $182 |
| Interest expense | $442 | $395 | $192 | $134 |
| Net income | ||||
| Net income | $2656 | -$2433 | $1284 | $1102 |
| Income (for common shares) | $2656 | -$2433 | $1284 | $1102 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$314 | $37 | $245 | |
| Operating activities | ||||
| Depreciation | $288 | $335 | $324 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $28 | $25 | $30 | |
| Total cash flows from operations | $115 | $163 | $531 | |
| Investing activities | ||||
| Capital expenditures | -$117 | -$182 | -$190 | |
| Investments | $18 | $16 | ||
| Total cash flows from investing | -$421 | -$91 | -$166 | -$230 |
| Financing activities | ||||
| Dividends paid | -$443 | -$148 | -$147 | -$147 |
| Sale and purchase of stock | $12 | $40 | $9 | |
| Net borrowings | -$809 | -$15 | -$2794 | |
| Total cash flows from financing | -$1222 | -$936 | -$140 | -$2935 |
| Effect of exchange rate | -$6 | -$22 | -$25 | $40 |
| Change in cash and equivalents | -$1118 | -$934 | -$168 | -$2594 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $2656 | -$2433 | $1284 | $1102 |
| Operating activities | ||||
| Depreciation | $1263 | $1403 | $890 | $823 |
| Business acquisitions & disposals | -$6 | -$263 | -$10502 | -$494 |
| Stock-based compensation | $133 | $154 | $146 | $130 |
| Total cash flows from operations | $1726 | $1211 | $2222 | $1868 |
| Investing activities | ||||
| Capital expenditures | -$692 | -$679 | -$743 | -$709 |
| Investments | ||||
| Total cash flows from investing | $3213 | -$931 | -$11200 | -$1179 |
| Financing activities | ||||
| Dividends paid | -$586 | -$573 | -$530 | -$473 |
| Sale and purchase of stock | $95 | $95 | -$413 | -$298 |
| Net borrowings | -$2933 | -$899 | $9228 | $478 |
| Total cash flows from financing | -$3489 | -$1438 | $8245 | -$345 |
| Effect of exchange rate | $26 | -$76 | -$47 | $57 |
| Change in cash and equivalents | $1476 | -$1234 | -$780 | $401 |
News
Fundamentals
| Market cap | $15.70B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 510.46M |
| Revenue | $13.99B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $108.00M |
| Revenue Q/Q | -27.21% |
| Revenue Y/Y | -6.44% |
| P/E ratio | 145.34 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.12 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $0.21 |
|---|---|
| ROA | 0.40% |
| ROE | N/A |
| Debt/Equity | 2.36 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.43 |
| Quick ratio | 1.09 |